CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 249 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is 2.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,222,431 | -17.2% | 22,037 | +11.6% | 0.01% | -11.1% |
| Q2 2023 | $2,683,963 | +5.9% | 19,751 | -19.0% | 0.01% | 0.0% |
| Q1 2023 | $2,533,249 | +2.0% | 24,391 | -12.9% | 0.01% | 0.0% |
| Q4 2022 | $2,483,072 | +22.1% | 28,013 | +10.4% | 0.01% | +12.5% |
| Q3 2022 | $2,034,000 | +5.1% | 25,375 | +25.6% | 0.01% | +14.3% |
| Q2 2022 | $1,935,000 | -26.8% | 20,202 | +13.5% | 0.01% | -12.5% |
| Q1 2022 | $2,645,000 | -5.7% | 17,806 | -10.0% | 0.01% | 0.0% |
| Q4 2021 | $2,804,000 | +3.4% | 19,778 | -4.6% | 0.01% | 0.0% |
| Q3 2021 | $2,711,000 | +10.4% | 20,723 | +16.0% | 0.01% | 0.0% |
| Q2 2021 | $2,455,000 | -6.9% | 17,865 | -11.6% | 0.01% | -11.1% |
| Q1 2021 | $2,638,000 | -10.9% | 20,201 | -23.6% | 0.01% | -10.0% |
| Q4 2020 | $2,961,000 | +45.1% | 26,437 | +1.9% | 0.01% | +25.0% |
| Q3 2020 | $2,040,000 | +3.4% | 25,934 | -5.3% | 0.01% | 0.0% |
| Q2 2020 | $1,972,000 | – | 27,395 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |